[Patients with cardiovascular risk. SH/fT study: mortality rate reduced by a fourth].
D001552:Benzazepines / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000037:antagonists & inhibitors*; D004359:Drug Therapy, Combination; D005858:Germany; D054143:Heart Failure, Systolic / Q000188:drug therapy* / Q000401:mortality*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D000077550:Ivabradine; D015337:Multicenter Studies as Topic; D010343:Patient Admission / Q000706:statistics & numerical data; D015996:Survival Rate
D001552:Benzazepines; D002317:Cardiovascular Agents; D054815:Cyclic Nucleotide-Gated Cation Channels; D000077550:Ivabradine